Assisted Reproductive Technology Market: Current Analysis and Forecast (2025-2033)

Assisted Reproductive Technology Market Size & Forecast

The Assisted Reproductive Technology market was valued at USD 23.41 billion in 2024 and is expected to grow at a strong CAGR of 9.56% for the forecast period (2025-2033F) due to the rising rate of abortion and congenital abnormalities.

Assisted Reproductive Technology Market Analysis

Assisted Reproductive Technology not only has helped create families, but has also given a distraught infertile couple a fresh perspective. The use of assisted reproductive technologies has opened up new possibilities for struggling infertile couples. Any device that manipulates gametes outside of the body is referred to as assisted reproductive technology (ART). It excludes procedures like intrauterine insemination (IUI), in which only spermatozoa are altered. The various procedures of ART include: In-vitro fertilization and embryo transfer (IVF &ET), Gamete Intrafallopian transfer (GIFT), Pronucleate or Zygote intra-fallopian transfer (PROT, ZIFT), Intracytoplasmic sperm injection (ICSI), Round nuclei injection (ROSNI) or spermatid injection, Assisted hatching, etc.

The rising prevalence of infertility across the population, technological advancements, social acceptance of ART, and increased awareness of ART are driving the assisted reproductive technology market. Further, inability of parents to conceive their child, increased rate of diseases such as greater body mass index, chronic hypertension, diabetes, and thyroid problems, are expediting its worldwide expansion. Additionally, better ART success rates and higher disposable income in developing nations are further propelling industry expansion throughout the forecast period. Sexually transmitted infections (STIs), rising cigarette smoking rates, obesity, endometriosis, and other conditions are further factors contributing to this market's significant rise.

Assisted Reproductive Technology Market Trends

This section discusses the key market trends influencing the various segments of the Assisted Reproductive Technology market as identified by our research experts.

The growing acceptance of ART in society is driving the growth of Assisted Reproductive Technology Markets.

The demand for ART procedures is anticipated to be driven by the increasing acceptance of ART in society. Further, social conventions and attitudes around parenthood, family formation, and reproductive choices have been drastically changed over time. Due to the advancement of more sophisticated technologies such as Magnet Activated Cell Sorting (MACS), Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), and time-lapse imaging of embryos, nowadays, ART is seen as a practical and empowering family planning choice rather than merely a last resort. The expansion of ART services can be attributed to the openness and improved accessibility, and affordability. Increased investment in ART infrastructure, research, and technology brought about by this wider acceptance. People seeking motherhood, Single-parent households, and same-sex couples are among the several family types that are now more widely accepted and acknowledged. For instance, according to the Department of Health, State Government of Victoria, Australia, in 2024, single-male-parent families are the fastest-growing family, rising from 44% to 65% by 2041.

Assisted Reproductive Technology Industry Segmentation

This section provides an analysis of the key trends in each segment of the global Assisted Reproductive Technology market report, along with forecasts at the global, regional, and country levels for 2025-2033.

The instrument product category dominates the Assisted Reproductive Technology market.

Based on product, the market is segmented into instruments, accessory & disposables, and reagents & media. The instrument-assisted reproductive technology market has the largest share in the assisted reproductive technology market because of its leadership in fertility treatment and the ongoing evolution of reproductive technology. Instruments such as Incubators, micromanipulators, imaging devices, and cryopreservation equipment are required for processes such as freezing sperm or eggs, embryo cultivation, and in vitro fertilization (IVF). Higher accuracy, automation, and efficiency in ART labs are also driving the usage of advanced instruments. Reproductive medicine research, ART success rates, and the growth in fertility clinics are other factors driving this market. Their market position is becoming dominant as the demand for high-quality instruments continues to rise, as ART procedures become more complex and common. According to the World Health Organization Statistics 2020, approximately 186 million people face problems related to infertility globally.

The in-vitro fertilization (IVF) technology dominates the Assisted Reproductive Technology market.

Based on technology category, the market is segmented into in-vitro fertilization (IVF), artificial insemination, and others. Among these, the largest portion of global revenue in 2024 came from the IVF category and has become the most successful method of treating infertility, addressing many factors such as older mother age, male factor, and unexplained infertility because of its high success rates, widespread use, and continuous technological advancements. Due to its great success, time-lapse imaging, embryo freezing, and preimplantation genetic screening are increasingly being used as the preferred ART method. Increased awareness of fertility treatment, increased infertility rates, and delayed conception are all contributing causes to the need for IVF worldwide. The development of fertility clinics worldwide, government support for ART therapy, and the rise in medical tourism are other factors driving the market leadership. According to the National Library of Medicine, in 2021, a total of 601 fertility clinics in Japan performed treatments of assisted reproductive technology (ART). Thus, the aforementioned factors are expected to augment the segmental growth.

North America held a dominant share of the Assisted Reproductive Technology market in 2024

North America held the greatest market share in 2024, making it the dominant region. With the rising infertility rates and greater knowledge of accessible fertility therapies, this region has stronger consumer demand. Additionally, the increased accessibility and utilization of ART operations have established the region as a reputable market for ART expansion. North America comprises developed nations like the United States, Canada, and Mexico. Due to their greater disposable income, people in these nations spend more on their food and general well-being. Furthermore, the increased use of ART procedures has been made possible by the healthcare system and a high level of disposable income.  Additionally, the region's market is growing due to the presence of top ART clinics and research facilities. Various organizations, such as the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology (SART), are working together to increase awareness about infertility treatment options. According to the World Bank Group, in 2024, the maternal mortality ratio in North America has remained stagnant over the last 20 years, roughly around 20, where 13 of every 1,000 girls ages 15-19 gave birth in North America in 2022.

The U.S. held a dominant share of the North American Assisted Reproductive Technology market in 2024

The market size of Assisted Reproductive Technology has grown significantly in the United States as a result of patients in the United States using fertility services at an increasing rate. In addition to, presence of state-of-the-art medical facilities and technology, the United States offers high-quality ART treatments and has enough money to cover expensive ART procedures like genetic testing and in vitro fertilization (IVF). Additionally, the U.S. is a leader in innovation since it is home to top research institutes and fertility clinics that are always improving ART techniques. Furthermore, ART is regulated in the United States, which attracts patients and clinicians due to its comparatively open regulatory structure that permits therapies to be pursued with greater flexibility than in some other nations. According to the Centers for Disease Control and Prevention, in 2021, 86,146 infants born (or 2.3% of all infants born in the U.S.) were conceived through the use of ART in the U.S. IVF enables individuals who use fertility preservation services to save their eggs, sperm, or reproductive tissues to have children at a later time.

Assisted Reproductive Technology Competitive Landscape

The Assisted Reproductive Technology Market is competitive and fragmented, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, and mergers and acquisitions.

Top Assisted Reproductive Technology Companies

The major players operating in the market are Thermo Fisher Scientific, Inc., Merck KGaA (E. Merck KG), and Vitrolife AB. (Vitrolife Group), FUJIFILM Irvine Scientific. (FUJIFILM Holdings Corporation), Hamilton Thorne Ltd., CooperSurgical, Inc. (The Cooper Companies, Inc.), Kitazato Corporation, NidaCon International AB., Gynotec, and Esco Medical.

Assisted Reproductive Technology Market News

• In January 2024, Ivy Fertility partnered with fertility specialty pharmacy SMP Pharmacy Solutions to enhance the patient experience across Ivy’s 13 fertility centers through a collaborative co-branding initiative. This strategic alliance aimed to optimize services and provide patients with comprehensive support, benefiting both companies through strengthened offerings and heightened patient satisfaction.
• In October 2023, Hamilton Thorne Ltd. acquired Gynetics Medical Products, N.V., and Gynetics Services B.V., a manufacturer of a diverse array of innovative and high-quality in vitro fertilization (IVF) devices in the global IVF market. This strategic acquisition significantly expanded Hamilton Thorne's product offerings, strengthening its presence and competitiveness in the IVF industry.

Assisted Reproductive Technology Market Report Coverage

Reasons to buy the Assisted Reproductive Technology Market report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report briefly reviews overall industry performance at a glance.
• The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional-level analysis of the industry.

Customization Options:

The Global Assisted Reproductive Technology Market can be customized by requirement or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.